{
  "DOI": "10.1038/ejhg.2008.264",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2008.264",
  "alternative-id": [
    "BFejhg2008264"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Need",
      "given": "Anna C",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Keefe",
      "given": "Richard SE",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ge",
      "given": "Dongliang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Grossman",
      "given": "Iris",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dickson",
      "given": "Sam",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "McEvoy",
      "given": "Joseph P",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Goldstein",
      "given": "David B",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2009,
        1,
        21
      ]
    ],
    "date-time": "2009-01-21T11:25:11Z",
    "timestamp": 1232537111000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T16:56:28Z",
    "timestamp": 1684428988000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        18
      ]
    ],
    "date-time": "2024-04-18T23:09:50Z",
    "timestamp": 1713481790255
  },
  "is-referenced-by-count": 78,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "7",
  "issued": {
    "date-parts": [
      [
        2009,
        1,
        21
      ]
    ]
  },
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2009,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2009,
            1,
            21
          ]
        ],
        "date-time": "2009-01-21T00:00:00Z",
        "timestamp": 1232496000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2008264.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2008264",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2008264.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "946-957",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2009,
        1,
        21
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2009,
        1,
        21
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2009,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJMoa051688",
      "author": "JA Lieberman",
      "doi-asserted-by": "publisher",
      "first-page": "1209",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2008264_CR1",
      "unstructured": "Lieberman JA, Stroup TS, McEvoy JP et al: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–1223.",
      "volume": "353",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.mp.4002142",
      "author": "PR Bakker",
      "doi-asserted-by": "publisher",
      "first-page": "544",
      "journal-title": "Mol Psychiatry",
      "key": "BFejhg2008264_CR2",
      "unstructured": "Bakker PR, van Harten PN, van Os J : Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions. Mol Psychiatry 2008; 13: 544–556.",
      "volume": "13",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.drudis.2007.07.018",
      "author": "GP Reynolds",
      "doi-asserted-by": "publisher",
      "first-page": "953",
      "journal-title": "Drug Discov Today",
      "key": "BFejhg2008264_CR3",
      "unstructured": "Reynolds GP : The impact of pharmacogenetics on the development and use of antipsychotic drugs. Drug Discov Today 2007; 12: 953–959.",
      "volume": "12",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.schres.2006.01.010",
      "author": "PR Bakker",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "Schizophr Res",
      "key": "BFejhg2008264_CR4",
      "unstructured": "Bakker PR, van Harten PN, van Os J : Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis. Schizophr Res 2006; 83: 185–192.",
      "volume": "83",
      "year": "2006"
    },
    {
      "DOI": "10.1093/schbul/sbn114",
      "author": "MJ Arranz",
      "doi-asserted-by": "publisher",
      "first-page": "1130",
      "journal-title": "Schizophr Bull",
      "key": "BFejhg2008264_CR5",
      "unstructured": "Arranz MJ, Kapur S : Pharmacogenetics in psychiatry: are we ready for widespread clinical use? Schizophr Bull 2008; 34: 1130–1144.",
      "volume": "34",
      "year": "2008"
    },
    {
      "DOI": "10.1017/S1461145707007547",
      "author": "V De Luca",
      "doi-asserted-by": "publisher",
      "first-page": "697",
      "journal-title": "Int J Neuropsychopharmacol",
      "key": "BFejhg2008264_CR6",
      "unstructured": "De Luca V, Mueller DJ, de Bartolomeis A, Kennedy JL : Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol 2007; 10: 697–704.",
      "volume": "10",
      "year": "2007"
    },
    {
      "DOI": "10.1097/00041444-200206000-00006",
      "author": "MC Athanasiou",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Psychiatr Genet",
      "key": "BFejhg2008264_CR7",
      "unstructured": "Athanasiou MC, Malhotra AK, Xu C, Stephens JC : Discovery and utilization of haplotypes for pharmacogenetic studies of psychotropic drug response. Psychiatr Genet 2002; 12: 89–96.",
      "volume": "12",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0140-6736(00)02221-2",
      "author": "MJ Arranz",
      "doi-asserted-by": "publisher",
      "first-page": "1615",
      "journal-title": "Lancet",
      "key": "BFejhg2008264_CR8",
      "unstructured": "Arranz MJ, Munro J, Birkett J et al: Pharmacogenetic prediction of clozapine response. Lancet 2000; 355: 1615–1616.",
      "volume": "355",
      "year": "2000"
    },
    {
      "DOI": "10.1176/appi.psy.47.1.75",
      "author": "J de Leon",
      "doi-asserted-by": "publisher",
      "first-page": "75",
      "journal-title": "Psychosomatics",
      "key": "BFejhg2008264_CR9",
      "unstructured": "de Leon J, Armstrong SC, Cozza KL : Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 2006; 47: 75–85.",
      "volume": "47",
      "year": "2006"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181863239",
      "author": "I Grossman",
      "doi-asserted-by": "publisher",
      "first-page": "720",
      "journal-title": "Genet Med",
      "key": "BFejhg2008264_CR10",
      "unstructured": "Grossman I, Sullivan PF, Walley N et al: Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study. Genet Med 2008; 10: 720–729.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.2217/14622416.8.10.1449",
      "author": "I Grossman",
      "doi-asserted-by": "publisher",
      "first-page": "1449",
      "journal-title": "Pharmacogenomics",
      "key": "BFejhg2008264_CR11",
      "unstructured": "Grossman I : Routine pharmacogenetic testing in clinical practice: dream or reality? Pharmacogenomics 2007; 8: 1449–1459.",
      "volume": "8",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.schres.2004.09.009",
      "author": "MF Green",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "journal-title": "Schizophr Res",
      "key": "BFejhg2008264_CR12",
      "unstructured": "Green MF, Kern RS, Heaton RK : Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 2004; 72: 41.",
      "volume": "72",
      "year": "2004"
    },
    {
      "DOI": "10.1002/j.2051-5545.2008.tb00140.x",
      "author": "DL Braff",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "World Psychiatry",
      "key": "BFejhg2008264_CR13",
      "unstructured": "Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ : Advances in endophenotyping schizophrenia. World Psychiatry 2008; 7: 11–18.",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.biopsych.2006.07.036",
      "author": "PF Sullivan",
      "doi-asserted-by": "publisher",
      "first-page": "902",
      "journal-title": "Biol Psychiatry",
      "key": "BFejhg2008264_CR14",
      "unstructured": "Sullivan PF, Keefe RS, Lange LA et al: NCAM1 and neurocognition in schizophrenia. Biol Psychiatry 2007; 61: 902–910.",
      "volume": "61",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.neuropharm.2007.06.016",
      "author": "EG Mohler",
      "doi-asserted-by": "publisher",
      "first-page": "563",
      "journal-title": "Neuropharmacology",
      "key": "BFejhg2008264_CR15",
      "unstructured": "Mohler EG, Shacham S, Noiman S et al: VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux. Neuropharmacology 2007; 53: 563–573.",
      "volume": "53",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.brainres.2006.08.108",
      "author": "V Micale",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "journal-title": "Brain Res",
      "key": "BFejhg2008264_CR16",
      "unstructured": "Micale V, Leggio GM, Mazzola C, Drago F : Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia. Brain Res 2006; 1121: 207–215.",
      "volume": "1121",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.brainres.2005.02.020",
      "author": "L Manuel-Apolinar",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "journal-title": "Brain Res",
      "key": "BFejhg2008264_CR17",
      "unstructured": "Manuel-Apolinar L, Rocha L, Pascoe D, Castillo E, Castillo C, Meneses A : Modifications of 5-HT4 receptor expression in rat brain during memory consolidation. Brain Res 2005; 1042: 73–81.",
      "volume": "1042",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.npp.1301196",
      "author": "FW Lohoff",
      "doi-asserted-by": "publisher",
      "first-page": "2739",
      "journal-title": "Neuropsychopharmacology",
      "key": "BFejhg2008264_CR18",
      "unstructured": "Lohoff FW, Dahl JP, Ferraro TN et al: Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder. Neuropsychopharmacology 2006; 31: 2739–2747.",
      "volume": "31",
      "year": "2006"
    },
    {
      "DOI": "10.1101/gr.071571.107",
      "author": "D Ge",
      "doi-asserted-by": "publisher",
      "first-page": "640",
      "journal-title": "Genome Res",
      "key": "BFejhg2008264_CR19",
      "unstructured": "Ge D, Zhang K, Need AC et al: WGAViewer: software for genomic annotation of whole genome association studies. Genome Res 2008; 18: 640–643.",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.1002/ajmg.b.30100",
      "author": "E Mundo",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "BFejhg2008264_CR20",
      "unstructured": "Mundo E, Altamura AC, Vismara S et al: MCP-1 gene (SCYA2) and schizophrenia: a case–control association study. Am J Med Genet B Neuropsychiatr Genet 2005; 132: 1–4.",
      "volume": "132",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.biopsych.2004.08.012",
      "author": "TW Weickert",
      "doi-asserted-by": "publisher",
      "first-page": "677",
      "journal-title": "Biol Psychiatry",
      "key": "BFejhg2008264_CR21",
      "unstructured": "Weickert TW, Goldberg TE, Mishara A et al: Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 2004; 56: 677–682.",
      "volume": "56",
      "year": "2004"
    },
    {
      "DOI": "10.1176/ajp.161.10.1798",
      "author": "A Bertolino",
      "doi-asserted-by": "publisher",
      "first-page": "1798",
      "journal-title": "Am J Psychiatry",
      "key": "BFejhg2008264_CR22",
      "unstructured": "Bertolino A, Caforio G, Blasi G et al: Interaction of COMT Val108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 2004; 161: 1798–1805.",
      "volume": "161",
      "year": "2004"
    },
    {
      "DOI": "10.1097/00008571-200405000-00005",
      "author": "S Anttila",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "Pharmacogenetics",
      "key": "BFejhg2008264_CR23",
      "unstructured": "Anttila S, Illi A, Kampman O, Mattila KM, Lehtimaki T, Leinonen E : Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics. Pharmacogenetics 2004; 14: 303–307.",
      "volume": "14",
      "year": "2004"
    },
    {
      "DOI": "10.1176/appi.ajp.158.5.802",
      "author": "M Schafer",
      "doi-asserted-by": "publisher",
      "first-page": "802",
      "journal-title": "Am J Psychiatry",
      "key": "BFejhg2008264_CR24",
      "unstructured": "Schafer M, Rujescu D, Giegling I et al: Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene. Am J Psychiatry 2001; 158: 802–804.",
      "volume": "158",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.euroneuro.2004.07.001",
      "author": "GP Reynolds",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "journal-title": "Eur Neuropsychopharmacol",
      "key": "BFejhg2008264_CR25",
      "unstructured": "Reynolds GP, Yao Z, Zhang X, Sun J, Zhang Z : Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response. Eur Neuropsychopharmacol 2005; 15: 143–151.",
      "volume": "15",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ajmg.b.20045",
      "author": "G Szekeres",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "BFejhg2008264_CR26",
      "unstructured": "Szekeres G, Keri S, Juhasz A et al: Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004; 124: 1–5.",
      "volume": "124",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s00213-002-1084-4",
      "author": "S Staddon",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "journal-title": "Psychopharmacology (Berl)",
      "key": "BFejhg2008264_CR27",
      "unstructured": "Staddon S, Arranz MJ, Mancama D, Mata I, Kerwin RW : Clinical applications of pharmacogenetics in psychiatry. Psychopharmacology (Berl) 2002; 162: 18–23.",
      "volume": "162",
      "year": "2002"
    },
    {
      "DOI": "10.1176/appi.ajp.159.9.1593",
      "author": "HY Lane",
      "doi-asserted-by": "publisher",
      "first-page": "1593",
      "journal-title": "Am J Psychiatry",
      "key": "BFejhg2008264_CR28",
      "unstructured": "Lane HY, Chang YC, Chiu CC, Chen ML, Hsieh MH, Chang WH : Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatry 2002; 159: 1593–1595.",
      "volume": "159",
      "year": "2002"
    },
    {
      "author": "R Joober",
      "first-page": "141",
      "journal-title": "J Psychiatry Neurosci",
      "key": "BFejhg2008264_CR29",
      "unstructured": "Joober R, Benkelfat C, Brisebois K et al: T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci 1999; 24: 141–146.",
      "volume": "24",
      "year": "1999"
    },
    {
      "DOI": "10.1001/archpsyc.64.6.633",
      "author": "RS Keefe",
      "doi-asserted-by": "publisher",
      "first-page": "633",
      "journal-title": "Arch Gen Psychiatry",
      "key": "BFejhg2008264_CR30",
      "unstructured": "Keefe RS, Bilder RM, Davis SM et al: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry 2007; 64: 633–647.",
      "volume": "64",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.schres.2004.09.010",
      "author": "SR Marder",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "journal-title": "Schizophr Res",
      "key": "BFejhg2008264_CR31",
      "unstructured": "Marder SR, Fenton W : Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res 2004; 72: 5–9.",
      "volume": "72",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nature07239",
      "author": "JL Stone",
      "doi-asserted-by": "publisher",
      "first-page": "237",
      "journal-title": "Nature",
      "key": "BFejhg2008264_CR32",
      "unstructured": "Stone JL, O’Donovan MC, Gurling H et al: Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455 (7210): 237–241.",
      "volume": "455",
      "year": "2008"
    },
    {
      "DOI": "10.1126/science.1155174",
      "author": "T Walsh",
      "doi-asserted-by": "publisher",
      "first-page": "539",
      "journal-title": "Science",
      "key": "BFejhg2008264_CR33",
      "unstructured": "Walsh T, McClellan JM, McCarthy SE et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539–543.",
      "volume": "320",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nrg2344",
      "author": "MI McCarthy",
      "doi-asserted-by": "publisher",
      "first-page": "356",
      "journal-title": "Nat Rev Genet",
      "key": "BFejhg2008264_CR34",
      "unstructured": "McCarthy MI, Abecasis GR, Cardon LR et al: Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356–369.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.biopsych.2007.04.018",
      "author": "DB Campbell",
      "doi-asserted-by": "publisher",
      "first-page": "32",
      "journal-title": "Biol Psychiatry",
      "key": "BFejhg2008264_CR35",
      "unstructured": "Campbell DB, Ebert PJ, Skelly T et al: Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia. Biol Psychiatry 2008; 63: 32–41.",
      "volume": "63",
      "year": "2008"
    },
    {
      "DOI": "10.1002/ajmg.b.30727",
      "author": "JJ Crowley",
      "doi-asserted-by": "publisher",
      "first-page": "1298",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "BFejhg2008264_CR36",
      "unstructured": "Crowley JJ, Keefe RS, Perkins DO, Stroup TS, Lieberman JA, Sullivan PF : The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1298–1300.",
      "volume": "147B",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.schres.2008.01.006",
      "author": "DB Campbell",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "journal-title": "Schizophr Res",
      "key": "BFejhg2008264_CR37",
      "unstructured": "Campbell DB, Lange LA, Skelly T, Lieberman J, Levitt P, Sullivan PF : Association of RGS2 and RGS5 variants with schizophrenia symptom severity. Schizophr Res 2008; 101: 67–75.",
      "volume": "101",
      "year": "2008"
    },
    {
      "DOI": "10.1080/00048670601109956",
      "author": "AP Pinheiro",
      "doi-asserted-by": "publisher",
      "first-page": "169",
      "journal-title": "Aust N Z J Psychiatry",
      "key": "BFejhg2008264_CR38",
      "unstructured": "Pinheiro AP, Keefe RS, Skelly T et al: AKT1 and neurocognition in schizophrenia. Aust N Z J Psychiatry 2007; 41: 169–177.",
      "volume": "41",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.biopsych.2006.07.036",
      "author": "PF Sullivan",
      "doi-asserted-by": "publisher",
      "first-page": "902",
      "journal-title": "Biol Psychiatry",
      "key": "BFejhg2008264_CR39",
      "unstructured": "Sullivan PF, Keefe RS, Lange LA et al: NCAM1 and neurocognition in schizophrenia. Biol Psychiatry 2007; 61: 902–910.",
      "volume": "61",
      "year": "2007"
    }
  ],
  "reference-count": 39,
  "references-count": 39,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2008264"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis"
  ],
  "type": "journal-article",
  "volume": "17"
}